Posted at 13:45h
in
Genetic Research,
OBGYNE
With rapid advancements in medical technology, prenatal screening now offers several safe, effective, and increasingly accurate avenues. These fall into two major categories: noninvasive screening tests and more conclusive diagnostic procedures. Early in pregnancy, noninvasive blood tests can detect hormone and protein levels that may point to an increased likelihood of chromosomal variations such as Down syndrome. Meanwhile, a nuchal translucency ultrasound assesses the fluid at the base of the fetus's neck, which can signal increased risk when combined with blood test results.